Advanced search
Publication Cover
Emerging Microbes & Infections Volume 13, 2024 - Issue 1
Submit an article Journal homepage
811
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Mpox virus Clade IIb infected Cynomolgus macaques via mimic natural infection routes closely resembled human mpox infection

Qingni Lia Biosafety Level 3 Laboratory, Wuhan Institute of Biological Products Co., Ltd., Wuhan, People’s Republic of ChinaView further author information
,
Yunfeng Chena Biosafety Level 3 Laboratory, Wuhan Institute of Biological Products Co., Ltd., Wuhan, People’s Republic of ChinaView further author information
,
Wenjing Zhanga Biosafety Level 3 Laboratory, Wuhan Institute of Biological Products Co., Ltd., Wuhan, People’s Republic of ChinaView further author information
,
Chunyang Lia Biosafety Level 3 Laboratory, Wuhan Institute of Biological Products Co., Ltd., Wuhan, People’s Republic of ChinaView further author information
,
Ding Tanga Biosafety Level 3 Laboratory, Wuhan Institute of Biological Products Co., Ltd., Wuhan, People’s Republic of ChinaView further author information
,
Wanlu Huaa Biosafety Level 3 Laboratory, Wuhan Institute of Biological Products Co., Ltd., Wuhan, People’s Republic of ChinaView further author information
,
Fan Houa Biosafety Level 3 Laboratory, Wuhan Institute of Biological Products Co., Ltd., Wuhan, People’s Republic of ChinaView further author information
,
Zhuo Chena Biosafety Level 3 Laboratory, Wuhan Institute of Biological Products Co., Ltd., Wuhan, People’s Republic of ChinaView further author information
,
Yuanlang Liua Biosafety Level 3 Laboratory, Wuhan Institute of Biological Products Co., Ltd., Wuhan, People’s Republic of ChinaView further author information
,
Yi Tiana Biosafety Level 3 Laboratory, Wuhan Institute of Biological Products Co., Ltd., Wuhan, People’s Republic of ChinaView further author information
,
Kaili Suna Biosafety Level 3 Laboratory, Wuhan Institute of Biological Products Co., Ltd., Wuhan, People’s Republic of ChinaView further author information
,
Xiuli Xua Biosafety Level 3 Laboratory, Wuhan Institute of Biological Products Co., Ltd., Wuhan, People’s Republic of ChinaView further author information
,
Yan Zenga Biosafety Level 3 Laboratory, Wuhan Institute of Biological Products Co., Ltd., Wuhan, People’s Republic of ChinaView further author information
,
Fei Xiaa Biosafety Level 3 Laboratory, Wuhan Institute of Biological Products Co., Ltd., Wuhan, People’s Republic of ChinaView further author information
,
Jia Lua Biosafety Level 3 Laboratory, Wuhan Institute of Biological Products Co., Ltd., Wuhan, People’s Republic of ChinaCorrespondence[email protected]
View further author information
&
Zejun Wanga Biosafety Level 3 Laboratory, Wuhan Institute of Biological Products Co., Ltd., Wuhan, People’s Republic of China;b National Engineering Technology Research Center for Combined Vaccines, Wuhan, People’s Republic of China;c National Key Laboratory for Novel Vaccines Research and Development of Emerging Infectious Diseases, Wuhan, People’s Republic of China;d Hubei Provincial Vaccine Technology Innovation Center, Wuhan, People’s Republic of ChinaCorrespondence[email protected]
View further author information
 show all
Article: 2332669 | Received 17 Dec 2023, Accepted 15 Mar 2024, Published online: 29 Mar 2024

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.